Incidence, Risk Factors and Outcomes of Early Acute Kidney Injury After Heart Transplantation: An 18-year Experience.
No Thumbnail Available
Identifiers
Date
2018
Authors
García-Gigorro, Renata
Renes-Carreño, Emilio
Corres Peiretti, María Angélica
Arribas López, Primitivo
Perez Vela, Jose Luis
Gutierrez Rodríguez, Julián
Delgado, Juan Francisco
Cortina Romero, Jose María
Montejo González, Juan Carlos
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Little is known about the incidence of acute kidney injury (AKI), as defined using the Kidney Disease Improving Global Outcome classification, after heart transplantation (HT). Our objective was to evaluate the impact of AKI in a cohort of HT recipients. (Setting: University Hospital.) METHODS: We studied 310 consecutive HT recipients from 1999 to 2017, with AKI being defined according to the Kidney Disease Improving Global Outcome criteria. Risk factors were analyzed by multivariable analyses, and survival by Kaplan-Meier curves and a risk-adjusted Cox proportional hazards regression model. One hundred twenty-five (40.3%) patients developed AKI, with 73 (23.5%), 18 (5.8%), and 34 (11%) patients having AKI stages 1, 2, and 3, respectively. Cardiac tamponade (odds ratio [OR], 16.82; 95% confidence interval [CI], 1.06-138), acute right ventricular failure (OR, 3.54; 95% CI, 1.82-6.88), and major bleeding (OR, 2.46; 95% CI, 1.18-5.1) were the principal risk factors for AKI. Patients with AKI had a greater hospital mortality (3.8% vs 16%, P The onset of AKI after HT is mainly associated with postoperative complications. Only severe AKI stage predicts worse short-term outcome, with this impact appearing to be lost at long-term follow-up.
Description
MeSH Terms
Acute Kidney Injury
Adult
Female
Heart Transplantation
Hospital Mortality
Humans
Incidence
Male
Middle Aged
Renal Replacement Therapy
Retrospective Studies
Risk Assessment
Risk Factors
Severity of Illness Index
Spain
Time Factors
Treatment Outcome
Adult
Female
Heart Transplantation
Hospital Mortality
Humans
Incidence
Male
Middle Aged
Renal Replacement Therapy
Retrospective Studies
Risk Assessment
Risk Factors
Severity of Illness Index
Spain
Time Factors
Treatment Outcome